The CEO told the bank in a letter that his condition was curable.
(Reporting by Sinchita Mitra in Bengaluru; Editing by Sherry Jacob-Phillips)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
202.3 GBX | +5.84% | +9.79% | +31.36% |
01:34pm | BARCLAYS : UBS reiterates its Buy rating | ZD |
12:02pm | Explainer-Where are Wall Street's analyst notes on Trump's Truth Social? | RE |
(Reuters) - British bank Barclays PLC said on Monday its chief executive officer C.S. Venkatakrishnan would be undergoing treatment for non-hodgkin's lymphoma, a type of cancer, and that this would mean he would work from home for some periods.
The CEO told the bank in a letter that his condition was curable.
(Reporting by Sinchita Mitra in Bengaluru; Editing by Sherry Jacob-Phillips)
1st Jan change | Capi. | |
---|---|---|
+31.36% | 35.63B | |
+13.51% | 555B | |
+13.81% | 301B | |
+9.16% | 249B | |
+23.12% | 212B | |
+17.11% | 172B | |
+7.31% | 161B | |
+4.13% | 153B | |
-0.51% | 137B | |
-11.61% | 138B |